Riskpilot← Back to searchSign inGet full accessKREFTKLINIKKEN AS
ASActiveOrg 925261947Olaf Helsets Vei 5, 0694 OsloMedical specialists activities · NACE 8622Est. 20207 employees
Revenue 2024
NOK 44,7M
+11% vs 2023
EBITDA margin
42.1%
+9% vs 2023
Equity ratio
2.7%
Financial strength
Net profit 2024
NOK 15M
+11% vs 2023
| Revenue | NOK 44,7M | +11% |
| EBITDA | NOK 18,9M | +9% |
| Net profit | NOK 15M | +11% |
| Total assets | NOK 22,5M | +7% |
| Equity | NOK 603K | +0% |
| Employees | 7 | — |
Legal name
KREFTKLINIKKEN AS
Org number
925261947
Legal form
Aksjeselskap
NACE code
8622 · Medical specialists activities
Founded
26. juni 2020
Share capital
NOK 30 000
Employees
7 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Company purpose
Behandling og utredning av pasienter med påvist eller mistenkt kreftsykdom.
Address
Olaf Helsets Vei 5, 0694 Oslo
Phone
+4721455535
Email
kontakt@kreftklinikken.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 19 342 | 29 939 | 35 529 | 40 299 | 44 747 |
| Staff expenses | −2 728 | −2 864 | −2 982 | −3 598 | −2 929 |
| EBITDA | 5 640 | 9 521 | 13 639 | 17 270 | 18 854 |
| Depreciation & amort. | −73 | −91 | −95 | −74 | −78 |
| EBIT | 5 567 | 9 431 | 13 544 | 17 195 | 18 776 |
| Net financials | 6 | −0 | 0 | 123 | 439 |
| Profit before tax | 5 573 | 9 430 | 13 544 | 17 318 | 19 215 |
| Tax | 1 227 | 2 075 | 2 984 | 3 826 | 4 216 |
| Net profit | 4 346 | 7 355 | 10 560 | 13 492 | 14 999 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 6 835 | 12 333 | 15 872 | 20 959 | 22 466 |
| Equity | 36 | 51 | 112 | 604 | 603 |
| Long-term debt | 2 761 | 36 | 3 | 0 | 12 |
| Short-term debt | 4 038 | 12 246 | 15 758 | 20 356 | 21 850 |
| Total debt | 6 799 | 12 282 | 15 760 | 20 356 | 21 863 |
EBITDA margin
42.1%
This company
15.8%
Market median
+166% vs market
20202024
Equity ratio
2.7%
This company
38.2%
Market median
-93% vs market
20202024
Return on equity
2487.2%
This company
18.4%
Market median
+13417% vs market
20202024
Net profit margin
33.5%
This company
8.1%
Market median
+314% vs market
20202024
Asset turnover
1.99×
This company
1.12×
Market median
+78% vs market
20202024
Debt / equity
36.25×
This company
0.62×
Market median
-5747% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
MH Chief Executive Officer | Chief Executive Officer | 2020 |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Fewi Holding As
KREFTKLINIKKEN AS Board members of KREFTKLINIKKEN AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Marius Haraldsen Normann | Chief Executive Officer | 0 companies |